Estimation of binding affinities for HEPT and nevirapine analogues with HIV-1 reverse transcriptase via Monte Carlo simulations.
暂无分享,去创建一个
[1] R T Walker,et al. Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. , 2010, Journal of medicinal chemistry.
[2] William L. Jorgensen,et al. Free Energy Changes in Solution , 2002 .
[3] W. L. Jorgensen,et al. Prediction of Properties from Simulations: Free Energies of Solvation in Hexadecane, Octanol, and Water , 2000 .
[4] William L. Jorgensen,et al. OPLS ALL-ATOM MODEL FOR AMINES : RESOLUTION OF THE AMINE HYDRATION PROBLEM , 1999 .
[5] M L Lamb,et al. Estimation of the binding affinities of FKBP12 inhibitors using a linear response method. , 1999, Bioorganic & medicinal chemistry.
[6] P A Kollman,et al. What determines the van der Waals coefficient β in the LIE (linear interaction energy) method to estimate binding free energies using molecular dynamics simulations? , 1999, Proteins.
[7] M. Summers,et al. Structural biology of HIV. , 1999, Journal of molecular biology.
[8] M L Lamb,et al. Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method. , 1998, Journal of medicinal chemistry.
[9] D I Stuart,et al. Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives. , 1998, Biochemistry.
[10] M L Lamb,et al. Computational approaches to molecular recognition. , 1997, Current opinion in chemical biology.
[11] Heather A. Carlson,et al. Free energies of solvation in chloroform and water from a linear response approach , 1997 .
[12] W. L. Jorgensen,et al. Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method. , 1997, Journal of medicinal chemistry.
[13] D I Stuart,et al. Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Åqvist,et al. Cyclic HIV-1 protease inhibitors derived from mannitol: synthesis, inhibitory potencies, and computational predictions of binding affinities. , 1997, Journal of medicinal chemistry.
[15] A. D. Clark,et al. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. , 1996, Journal of molecular biology.
[16] Gerhard Klebe,et al. What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .
[17] W. L. Jorgensen,et al. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .
[18] Elizabeth Wilson,et al. AIDS CONFERENCE HIGHLIGHTS HOPE OF DRUG COCKTAILS, CHEMOKINE RESEARCH , 1996 .
[19] B. Honig,et al. New Model for Calculation of Solvation Free Energies: Correction of Self-Consistent Reaction Field Continuum Dielectric Theory for Short-Range Hydrogen-Bonding Effects , 1996 .
[20] R. Ornstein,et al. Binding free energy calculations for P450cam-substrate complexes. , 1996, Protein engineering.
[21] M. Eigen. On the nature of virus quasispecies. , 1996, Trends in microbiology.
[22] Richard T. Walker,et al. Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. , 1996, Journal of medicinal chemistry.
[23] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[24] P. Kollman,et al. Investigating the Anomalous Solvation Free Energies of Amines with a Polarizable Potential , 1996 .
[25] T. Hansson,et al. Estimation of binding free energies for HIV proteinase inhibitors by molecular dynamics simulations. , 1995, Protein engineering.
[26] D. Stuart,et al. The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design. , 1995, Structure.
[27] Ronald M. Levy,et al. SOLVATION FREE ENERGIES OF SMALL AMIDES AND AMINES FROM MOLECULAR DYNAMICS/FREE ENERGY PERTURBATION SIMULATIONS USING PAIRWISE ADDITIVE AND MANY-BODY POLARIZABLE POTENTIALS , 1995 .
[28] P. Boyer,et al. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase. , 1995, Virology.
[29] Peter A. Kollman,et al. Solvation Free Energies of Amides and Amines: Disagreement between Free Energy Calculations and Experiment , 1995 .
[30] W. L. Jorgensen,et al. AN EXTENDED LINEAR RESPONSE METHOD FOR DETERMINING FREE ENERGIES OF HYDRATION , 1995 .
[31] A. D. Clark,et al. Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor α-APA R 95845 at 2.8 å resolution , 1995 .
[32] Yvonne Jones,et al. High resolution structures of HIV-1 RT from four RT–inhibitor complexes , 1995, Nature Structural Biology.
[33] Jianping Ding,et al. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. , 1994, Journal of molecular biology.
[34] E. De Clercq,et al. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Dunitz. The entropic cost of bound water in crystals and biomolecules. , 1994, Science.
[36] T. Steitz,et al. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[37] S Shigeta,et al. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[38] J. Aqvist,et al. A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.
[39] E. Clercq. HIV resistance to reverse transcriptase inhibitors , 1994 .
[40] Peter A. Kollman,et al. FREE ENERGY CALCULATIONS : APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA , 1993 .
[41] R T Walker,et al. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. , 1992, Journal of medicinal chemistry.
[42] R T Walker,et al. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity. , 1992, Journal of medicinal chemistry.
[43] J. Proudfoot,et al. Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones. , 1991, Journal of medicinal chemistry.
[44] H. Mitsuya,et al. Molecular targets for AIDS therapy. , 1990, Science.
[45] W. L. Jorgensen. Free energy calculations: a breakthrough for modeling organic chemistry in solution , 1989 .
[46] L. Loeb,et al. Fidelity of HIV-1 reverse transcriptase. , 1988, Science.
[47] K Bebenek,et al. The accuracy of reverse transcriptase from HIV-1. , 1988, Science.
[48] W. L. Jorgensen,et al. Monte Carlo simulation of differences in free energies of hydration , 1985 .
[49] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[50] R. Wolfenden,et al. Interaction of the peptide bond with solvent water: a vapor phase analysis. , 1978, Biochemistry.
[51] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[52] Johan Åqvist,et al. Ligand binding affinity prediction by linear interaction energy methods , 1998, J. Comput. Aided Mol. Des..
[53] A. Skalka,et al. The retroviral enzymes. , 1994, Annual review of biochemistry.
[54] S Shigeta,et al. A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). , 1991, Journal of medicinal chemistry.
[55] J Sninsky,et al. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. , 1989, Journal of acquired immune deficiency syndromes.